These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11206453)

  • 1. Atropisomeric quinazolin-4-one derivatives are potent noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists.
    Welch WM; Ewing FE; Huang J; Menniti FS; Pagnozzi MJ; Kelly K; Seymour PA; Guanowsky V; Guhan S; Guinn MR; Critchett D; Lazzaro J; Ganong AH; DeVries KM; Staigers TL; Chenard BL
    Bioorg Med Chem Lett; 2001 Jan; 11(2):177-81. PubMed ID: 11206453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.
    Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG
    J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinazolin-4-one alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists: structure-activity relationship of the C-2 side chain tether.
    Chenard BL; Welch WM; Blake JF; Butler TW; Reinhold A; Ewing FE; Menniti FS; Pagnozzi MJ
    J Med Chem; 2001 May; 44(11):1710-7. PubMed ID: 11356106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7,8-Methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists.
    De Sarro A; De Sarro G; Gitto R; Grasso S; Micale N; Quartarone S; Zappalà M
    Bioorg Med Chem Lett; 1998 Apr; 8(8):971-6. PubMed ID: 9871522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, structure-activity relationships, and anticonvulsant activities of 2-amino-4H-pyrido[3,2-e][1,3]thiazin-4-one derivatives as orally active AMPA receptor antagonists.
    Inami H; Shishikura J; Yasunaga T; Ohno K; Yamashita H; Kato K; Sakamoto S
    Bioorg Med Chem; 2015 Apr; 23(8):1788-99. PubMed ID: 25792143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3,5-Dihydro-4H-2,3-benzodiazepine-4-thiones: a new class of AMPA receptor antagonists.
    Chimirri A; De Sarro G; De Sarro A; Gitto R; Quartarone S; Zappalà M; Constanti A; Libri V
    J Med Chem; 1998 Aug; 41(18):3409-16. PubMed ID: 9719593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of some selected 4,5-dihydro-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates and 3-hydroxyquinazoline-2,4-diones as (S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor antagonists.
    Catarzi D; Lenzi O; Colotta V; Varano F; Poli D; Filacchioni G; Lingenhöhl K; Ofner S
    Chem Pharm Bull (Tokyo); 2010 Jul; 58(7):908-11. PubMed ID: 20606335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and potent anticonvulsant activities of 4-oxo-imidazo[1,2-a]inden.
    Pratt J; Jimonet P; Bohme GA; Boireau A; Damour D; Debono MW; Genevois-Borella A; Randle JC; Ribeill Y; Stutzmann JM; Vuilhorgne M; Mignani S
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2749-54. PubMed ID: 11133083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of CP-465,022, a selective, noncompetitive AMPA receptor antagonist.
    Lazzaro JT; Paternain AV; Lerma J; Chenard BL; Ewing FE; Huang J; Welch WM; Ganong AH; Menniti FS
    Neuropharmacology; 2002 Feb; 42(2):143-53. PubMed ID: 11804610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-aryl-6,7-methylenedioxy-3H-quinazolin-4-ones as anticonvulsant agents.
    Zappalà M; Grasso S; Micale N; Zuccalà G; Menniti FS; Ferreri G; De Sarro G; De Micheli C
    Bioorg Med Chem Lett; 2003 Dec; 13(24):4427-30. PubMed ID: 14643339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioisosteres of 9-carboxymethyl-4-oxo-imidazo[1,2-a]indeno-[1,2-e]pyrazin-2-carboxylic acid derivatives. Progress towards selective, potent in vivo AMPA antagonists with longer durations of action.
    Jimonet P; Bohme GA; Bouquerel J; Boireau A; Damour D; Debono MW; Genevois-Borella A; Hardy JC; Hubert P; Manfré F; Nemecek P; Pratt J; Randle JC; Ribeill Y; Stutzmann JM; Vuilhorgne M; Mignani S
    Bioorg Med Chem Lett; 2001 Jan; 11(2):127-32. PubMed ID: 11206442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist.
    Gitto R; Barreca ML; De Luca L; De Sarro G; Ferreri G; Quartarone S; Russo E; Constanti A; Chimirri A
    J Med Chem; 2003 Jan; 46(1):197-200. PubMed ID: 12502375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anticonvulsant activity of novel and potent 2,3-benzodiazepine AMPA/kainate receptor antagonists.
    Grasso S; De Sarro G; De Sarro A; Micale N; Zappalà M; Puia G; Baraldi M; De Micheli C
    J Med Chem; 1999 Oct; 42(21):4414-21. PubMed ID: 10543885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the binding site for a novel class of noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonists.
    Menniti FS; Chenard BL; Collins MB; Ducat MF; Elliott ML; Ewing FE; Huang JI; Kelly KA; Lazzaro JT; Pagnozzi MJ; Weeks JL; Welch WM; White WF
    Mol Pharmacol; 2000 Dec; 58(6):1310-7. PubMed ID: 11093768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel potent AMPA/kainate receptor antagonists: synthesis and anticonvulsant activity of a series of 2-[(4-alkylsemicarbazono)-(4-amino-phenyl)methyl]-4,5-methylenedioxyphenylacetic acid alkyl esters.
    Micale N; Zappalà M; Grasso S; Puja G; De Sarro G; Ferreri G; De Sarro A; Toma L; De Micheli C
    J Med Chem; 2002 Sep; 45(20):4433-42. PubMed ID: 12238923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonists.
    Orain D; Ofner S; Koller M; Carcache DA; Froestl W; Allgeier H; Rasetti V; Nozulak J; Mattes H; Soldermann N; Floersheim P; Desrayaud S; Kallen J; Lingenhoehl K; Urwyler S
    Bioorg Med Chem Lett; 2012 Jan; 22(2):996-9. PubMed ID: 22197388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of YM928, a novel moncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist.
    Ohno K; Tsutsumi R; Matsumoto N; Yamashita H; Amada Y; Shishikura J; Yatsugi HI; Okada M; Sakamoto S; Yamaguchi T
    J Pharmacol Exp Ther; 2003 Jul; 306(1):66-72. PubMed ID: 12660313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4,10-Dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives: highly potent and selective AMPA receptors antagonists with in vivo activity.
    Stutzmann JM; Bohme GA; Boireau A; Damour D; Debono MW; Genevois-Borella A; Imperato A; Jimonet P; Pratt J; Randle JC; Ribeill Y; Vuilhorgne M; Mignani S
    Bioorg Med Chem Lett; 2000 May; 10(10):1133-7. PubMed ID: 10843235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Pharmacological Evaluation of 3-[(4-Oxo-4H-pyrido[3,2-e][1,3]thiazin-2-yl)(phenyl)amino]propanenitrile Derivatives as Orally Active AMPA Receptor Antagonists.
    Inami H; Shishikura JI; Yasunaga T; Hirano M; Kimura T; Yamashita H; Ohno K; Sakamoto S
    Chem Pharm Bull (Tokyo); 2019; 67(7):699-706. PubMed ID: 31257325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CP-465,022, a selective noncompetitive AMPA receptor antagonist, blocks AMPA receptors but is not neuroprotective in vivo.
    Menniti FS; Buchan AM; Chenard BL; Critchett DJ; Ganong AH; Guanowsky V; Seymour PA; Welch WM
    Stroke; 2003 Jan; 34(1):171-6. PubMed ID: 12511770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.